Cellectis SA Chardan Leadership Call Transcript
Good morning, and good afternoon to call participants in Europe. Welcome to today's Chardan Leadership Call featuring Cellectis, a company focused on developing off-the-shelf T-cell therapies for cancers.
A special thank you to our guests today, Dr. André Choulika, CEO; Dr. Carrie Brownstein, CMO; and Simon Harnest, VP of Corporate Strategy and Finance, of Cellectis. So Cellectis is participating in this leadership call in conjunction with Chardan Cares, Chardan's fundraising initiative to support the programs and charities that are most important to the companies we work with. Chardan has made a donation to the Multiple Myeloma Research Foundation in Cellectis's name, and we encourage you to support this charity as well as you are able to. For more information, please reach out to our corporate access team.
I'm Geulah Livshits, a biotech analyst at Chardan. And as call participants are aware, our focus at Chardan is on identifying companies that can generate exceptionally high, long-term investment returns by creating and sharing in real
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |